Stocktoria

3M CO MMM

NYSE · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1946-01-14 · LEI

3M CO financials (annual)

Revenue
$30.11B $31.66B $32.77B $32.14B $32.18B $35.35B $26.16B $24.61B $24.57B $24.95B 2016201720182019202020212022202320242025
Net income
$5.05B $4.86B $5.35B $4.52B $5.45B $5.92B $5.78B -$7.00B $4.17B $3.25B 2016201720182019202020212022202320242025
Free cash flow
$5.24B $4.87B $4.86B $5.37B $6.61B $5.85B $3.84B $5.07B $638.0M $1.40B 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$24.9B$24.6B$24.6B$26.2B$35.4B$32.2B$32.1B$32.8B$31.7B$30.1B
R&D expense$700.0M$700.0M$800.0M$1.2B$1.1B$1.3B$1.3B$1.4B$1.2B
SG&A expense$4.0B$4.2B$19.2B$7.2B$7.2B$6.9B$7.0B$7.6B$6.6B$6.3B
Operating income$4.6B$4.8B-$10.7B$4.4B$7.4B$7.2B$6.2B$7.2B$7.7B$7.0B
Interest expense$942.0M$462.0M$488.0M$529.0M$448.0M$350.0M$322.0M$199.0M
Income tax$1.0B$804.0M-$2.9B$188.0M$1.3B$1.3B$1.1B$1.6B$2.7B$2.0B
Net income$3.2B$4.2B-$7.0B$5.8B$5.9B$5.4B$4.5B$5.3B$4.9B$5.0B
EPS (diluted)$6.00$7.55$-12.63$10.18$10.12$9.36$7.72$8.89$7.93$8.16
Operating cash flow$2.3B$1.8B$6.7B$5.6B$7.5B$8.1B$7.1B$6.4B$6.2B$6.7B
Free cash flow$1.4B$638.0M$5.1B$3.8B$5.9B$6.6B$5.4B$4.9B$4.9B$5.2B
Cash & equivalents$2.4B
Inventory$3.7B$3.7B$3.9B$5.4B$5.0B$4.2B$4.1B$4.4B$4.0B$3.4B
Total assets$37.7B$39.9B$50.6B$46.5B$47.1B$47.3B$44.7B$36.5B$38.0B$32.9B
Total liabilities$33.0B$36.0B$45.7B$31.7B$32.0B$34.4B$34.5B$26.7B$26.4B$22.6B
Shareholders' equity$4.7B$3.9B$4.9B$14.8B$15.1B$12.9B$10.1B$9.8B$11.6B$10.3B

Growth · year-over-year · Revenue CAGR -2.1%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+1.5%-0.1%-5.9%-26.0%+9.9%+0.1%-1.9%+3.5%+5.1%-0.5%
Net income growth-22.1%-221.1%-2.4%+8.7%+20.6%-15.6%+10.1%-3.8%+4.5%
EPS growth-20.5%-224.1%+0.6%+8.1%+21.2%-13.2%+12.1%-2.8%+7.7%
Free cash flow growth+118.8%-87.4%+31.8%-34.3%-11.5%+23.1%+10.5%-0.1%-7.2%+5.7%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.